Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia

Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia - Efficacy of glucose infusion for the inhibition of breakdown of fat tissue and muscle protein under anesthesia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007094

Enrollment

120

Registered

2012-02-01

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical disease

Interventions

Glucose was administered at the rate of 2mg/kg/min. Glucose was not administered.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ASA physical status 1 or 2

Exclusion criteria

Exclusion criteria: Patients with endocrine disease or disorder of metabolism, patients with heart failure or renal failure

Design outcomes

Primary

Measure	Time frame
Plasma concentrations of acetoacetic acid and 3-hydroxybutyrate acid and urine 3-methylhistidine/plasma creatinine	—

Countries

Japan

Contacts

Public ContactAtsushi Sawada

Sapporo Medical University Department of Anesthesiology

011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026